APA (7th ed.) Citation

AB, E., CH, L., GK, A., AM, T., D, M., DL, H., . . . AJ, B. (2026). A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma. Liver cancer. https://doi.org/10.1159/000551630

Chicago Style (17th ed.) Citation

AB, El-Khoueiry, et al. "A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma." Liver Cancer 2026. https://doi.org/10.1159/000551630.

MLA (9th ed.) Citation

AB, El-Khoueiry, et al. "A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma." Liver Cancer, 2026, https://doi.org/10.1159/000551630.